Angioblast Systems

Angioblast Systems is a biotechnology company dedicated to the development and commercialization of therapeutic products for heart disease, vascular disease, and eye disease. It provides adult stem cells, protein therapies, gene silencing, small molecule peptides and antibodies, cytokines and antigen receptor inhibitors, DNAzymes, as well as MPC products for heart failure, heart attacks, peripheral artery disease, and wound ulcers.